International Biotechnology Trust’s Exact Sciences EXAS Stock Holding History

International Biotechnology Trust’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,700	Closed	-$833K	–	75
2021 Q4	$833K	Hold	10,700	–	–	0.19%	61
2021 Q3	$1.02M	Hold	10,700	–	–	0.25%	54
2021 Q2	$1.33M	Hold	10,700	–	–	0.35%	48
2021 Q1	$1.41M	Hold	10,700	–	–	0.37%	42
2020 Q4	$1.42M	Hold	10,700	–	–	0.39%	38
2020 Q3	$1.09M	Hold	10,700	–	–	0.35%	41
2020 Q2	$920K	Hold	10,700	–	–	0.31%	44
2020 Q1	$619K	Hold	10,700	–	–	0.28%	49
2019 Q4	$989K	Hold	10,700	–	–	0.36%	48
2019 Q3	$967K	Hold	10,700	–	–	0.45%	42
2019 Q2	$1.26M	Buy	+10,700	New	+$1.08M	0.47%	46

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

International Biotechnology Trust's EXAS Position: Q1 2022 in Review

International Biotechnology Trust sold out of Exact Sciences (EXAS) in Q1 2022, closing a stake of 10,700 shares — an estimated $833K sold.

International Biotechnology Trust first reported a position in EXAS in Q2 2019 and held it in 11 quarters. The position peaked at $1.42M in Q4 2020. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

International Biotechnology Trust reported no remaining Exact Sciences position as of Q1 2022 after selling out during the quarter.
International Biotechnology Trust sold 10,700 Exact Sciences shares in Q1 2022, an estimated $833K.
International Biotechnology Trust first reported a position in Exact Sciences in Q2 2019 and held it in 11 quarters.
International Biotechnology Trust's Exact Sciences position peaked at $1.42M in Q4 2020.
559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on International Biotechnology Trust's 13F filing for Q1 2022, filed 20 May 2022.